Jacobson Pharma Corporation Limited released its earnings results on Jun 13, 2025. The company reported HK$0.08 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.08.

Is Jacobson Pharma Corporation Limited overvalued?

According to Wall Street analysts Jacobson Pharma Corporation Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Jacobson Pharma Corporation Limited pay dividends?

Jacobson Pharma Corporation Limited pays a Annually dividend of HK$0.064 which represents an annual dividend yield of 4.93%. See more information on Jacobson Pharma Corporation Limited dividends here

What is Jacobson Pharma Corporation Limited’s EPS estimate?

Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Jacobson Pharma Corporation Limited have?

Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.

What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?

Jacobson Pharma Corporation Limited reported an EPS of HK$0.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.65%.

Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?

Currently, no hedge funds are holding shares in HK:2633

Jacobson Pharma Corporation Limited Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

12.47%

Trailing 12-Months

Asset Growth

4.54%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Jacobson Pharma Corporation Limited

Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.